Injection laryngoplasty
Injection laryngoplasty
复制标题
DOI：
10.1016/j.otc.2003.12.002
复制
发表时间：
2004-02-01
影响因子：
1.7
通讯作者：
Courey, MS
中科院分区：
文献类型：
--
作者：
Courey, MS
注射喉成形术最初由Bruning于1911年引入，用于治疗继发于单侧声带麻痹的发音困难。到20世纪60年代初，特氟龙已成为最常用的注射用物质。然而，由于宿主对特氟隆的炎症反应不可预测，以及特氟隆与声带振动膜之间的粘度匹配较差，因此一直在寻找替代物质。硅胶、软骨、骨粉、脂肪、筋膜、胶原蛋白、透明质酸和羟基磷灰石已被使用。物质的选择取决于造成发音困难的声门功能不全的原因以及要注射的声带层。对喉组织学和生理学的了解使外科医生能够更好地评估潜在的选择。
Injection laryngoplasty was originally introduced in 1911 by Bruening for the management of dysphonia secondary to unilateral vocal fold paralysis. By the early 1960s, Teflon had become the most commonly employed substance for injection. Because of an unpredictable inflammatory response in the host to the Teflon and a poor viscosity match between the Teflon and the vibratory membrane of the vocal fold, however, the search has been ongoing for an alternative substance. Silicone, cartilage, bone powder, fat, fascia, collagen, hyaluronan, and hydroxyapatite have been used. The choice of substance is dependent on the cause of the glottic insufficiency creating the dysphonia as well as on the layer of the vocal fold to be injected. An understanding of laryngeal histology and physiology enables the surgeon to evaluate the potential options better.